• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Lina,ZHOU Guangjie,WANG Bing,YUAN Minghui,GAO Na.A case of gross hematuria induced by Piperacillin-tazobactam Sodium[J].Journal Of Pharmaceutical Research,2022,41(5):349-350[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2386times   Download 2168次 QR Code for this article
Scan with your phone!
哌拉西林他唑巴坦钠致肉眼血尿1例
张丽娜1,周广洁1,王冰1,袁明辉2,高娜1
Font:Larger+|Default|Smaller-
(1.山东大学附属威海市立医院,山东 威海 264200;2.威海市药品不良反应监测中心,山东 威海 264200)
摘要:
1例46岁男性患者,因“左侧肢体活动不利6月余”入院行康复治疗,入院后出现发热、白细胞、中性粒细胞百分比、C-反应蛋白升高现象,给予注射用哌拉西林他唑巴坦钠(4.5 g,ivdrip,q8 h)抗感染治疗,当日夜间患者出现肉眼血尿。第2d尿常规示:红细胞8493/μL;第3d肉眼血尿加重,尿常规示红细胞16 469·μL-1,考虑哌拉西林他唑巴坦钠致血尿,立即停用,改用左氧氟沙星氯化钠注射液(0.5 g,qd,ivdrip)治疗。2 d后尿常规示:红细胞8 675·μL-1;5 d后尿常规示:红细胞64·μL-1,已无肉眼血尿。至2020.09.21患者未再出现肉眼血尿。
关键词:  哌拉西林他唑巴坦钠  肉眼血尿  不良反应
DOI:10.13506/j.cnki.jpr.2022.05.017
基金项目:
Publication Date:May 25, 2022
A case of gross hematuria induced by Piperacillin-tazobactam Sodium
ZHANG Lina1,ZHOU Guangjie1,WANG Bing1,YUAN Minghui2,GAO Na1
(Department of Pharmary,Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai 264200,China)
Abstract:
A 46-year-old male patient was admitted to the hospital for rehabilitation treatment due to "poor left limb movement for more than 6 months". Fever, white blood cells, percentage of neutrophils, and c-reactive protein levels were increased after admission. Piperacillin-tazobactam sodium (4.5g, q8h, ivdrip) was given to him for infection. Gross hematuria appeared at the night. On the 2nd day after treatment, and the routine urine: erythrocyte 8493/μL. On the 3rd day after the treatment, the gross hematuria was increased, and the routine urine: erythrocyte 16469/μL. The adverse reaction of Piperacillin-tazobactam sodium was considered. Piperacillin-tazobactam sodium was immediately discontinued and changed to Levofloxacin and Sodium Chloride Injection (2.0 g, q 12 h, ivdrip). After 2 days, the routine urine: erythrocyte 8675/μL. After 5 days, routine urine:erythrocyte 64/μL. The patient had no gross hematuria untill 2020.09.21.
Key words:  Piperacillin-tazobactam sodium  Gross hematuria  Adverse reaction
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.